Selected research
Industry Growth & Trends
Global Hydrophilic Coronary Stents Industry Growth and Trends Forecast to 2032
Market perspective
The global Hydrophilic Coronary Stents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hydrophilic Coronary Stents include Lepu Medical, USM Healthcare Medical Devices Factory, Rontis Medical, Meril Life Sciences, Genoss, Degania Silicone and Cardionovum, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Hydrophilic Coronary Stents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hydrophilic Coronary Stents market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydrophilic Coronary Stents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydrophilic Coronary Stents.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hydrophilic Coronary Stents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hydrophilic Coronary Stents Market by Company
Lepu Medical
USM Healthcare Medical Devices Factory
Rontis Medical
Meril Life Sciences
Genoss
Degania Silicone
Cardionovum
Hydrophilic Coronary Stents Segment by Type
Metal Stents
Polymer Stents
Hydrophilic Coronary Stents Segment by Application
Drug-Eluting
Post-Procedure Management
Percutaneous Coronary Intervention (PCI)
Hydrophilic Coronary Stents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrophilic Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydrophilic Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrophilic Coronary Stents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydrophilic Coronary Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hydrophilic Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metal Stents
- Polymer Stents
Applications
- Drug-Eluting
- Post-Procedure Management
- Percutaneous Coronary Intervention (PCI)
Companies covered
- Lepu Medical
- USM Healthcare Medical Devices Factory
- Rontis Medical
- Meril Life Sciences
- Genoss
- Degania Silicone
- Cardionovum
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hydrophilic Coronary Stents Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hydrophilic Coronary Stents Sales Estimates and Forecasts (2021-2032)
- 1.3 Hydrophilic Coronary Stents Market by Type
- 1.3.1 Metal Stents
- 1.3.2 Polymer Stents
- 1.4 Global Hydrophilic Coronary Stents Market Size by Type
- 1.4.1 Global Hydrophilic Coronary Stents Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hydrophilic Coronary Stents Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hydrophilic Coronary Stents Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hydrophilic Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hydrophilic Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hydrophilic Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hydrophilic Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hydrophilic Coronary Stents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hydrophilic Coronary Stents Industry Trends
- 2.2 Hydrophilic Coronary Stents Industry Drivers
- 2.3 Hydrophilic Coronary Stents Industry Opportunities and Challenges
- 2.4 Hydrophilic Coronary Stents Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hydrophilic Coronary Stents Revenue (2021-2026)
- 3.2 Global Top Players by Hydrophilic Coronary Stents Sales (2021-2026)
- 3.3 Global Top Players by Hydrophilic Coronary Stents Price (2021-2026)
- 3.4 Global Hydrophilic Coronary Stents Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hydrophilic Coronary Stents Major Company Production Sites & Headquarters
- 3.6 Global Hydrophilic Coronary Stents Company, Product Type & Application
- 3.7 Global Hydrophilic Coronary Stents Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hydrophilic Coronary Stents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hydrophilic Coronary Stents Players Market Share by Revenue in 2025
- 3.8.3 2025 Hydrophilic Coronary Stents Tier 1, Tier 2, and Tier 3
4 Hydrophilic Coronary Stents Regional Status and Outlook
- 4.1 Global Hydrophilic Coronary Stents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hydrophilic Coronary Stents Historic Market Size by Region
- 4.2.1 Global Hydrophilic Coronary Stents Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hydrophilic Coronary Stents Sales in Value by Region (2021-2026)
- 4.2.3 Global Hydrophilic Coronary Stents Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hydrophilic Coronary Stents Forecasted Market Size by Region
- 4.3.1 Global Hydrophilic Coronary Stents Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hydrophilic Coronary Stents Sales in Value by Region (2027-2032)
- 4.3.3 Global Hydrophilic Coronary Stents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydrophilic Coronary Stents by Application
- 5.1 Hydrophilic Coronary Stents Market by Application
- 5.1.1 Drug-Eluting
- 5.1.2 Post-Procedure Management
- 5.1.3 Percutaneous Coronary Intervention (PCI)
- 5.2 Global Hydrophilic Coronary Stents Market Size by Application
- 5.2.1 Global Hydrophilic Coronary Stents Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hydrophilic Coronary Stents Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hydrophilic Coronary Stents Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hydrophilic Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hydrophilic Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hydrophilic Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hydrophilic Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hydrophilic Coronary Stents Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Lepu Medical
- 6.1.1 Lepu Medical Company Information
- 6.1.2 Lepu Medical Business Overview
- 6.1.3 Lepu Medical Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Lepu Medical Hydrophilic Coronary Stents Product Portfolio
- 6.1.5 Lepu Medical Recent Developments
- 6.2 USM Healthcare Medical Devices Factory
- 6.2.1 USM Healthcare Medical Devices Factory Company Information
- 6.2.2 USM Healthcare Medical Devices Factory Business Overview
- 6.2.3 USM Healthcare Medical Devices Factory Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 USM Healthcare Medical Devices Factory Hydrophilic Coronary Stents Product Portfolio
- 6.2.5 USM Healthcare Medical Devices Factory Recent Developments
- 6.3 Rontis Medical
- 6.3.1 Rontis Medical Company Information
- 6.3.2 Rontis Medical Business Overview
- 6.3.3 Rontis Medical Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Rontis Medical Hydrophilic Coronary Stents Product Portfolio
- 6.3.5 Rontis Medical Recent Developments
- 6.4 Meril Life Sciences
- 6.4.1 Meril Life Sciences Company Information
- 6.4.2 Meril Life Sciences Business Overview
- 6.4.3 Meril Life Sciences Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Meril Life Sciences Hydrophilic Coronary Stents Product Portfolio
- 6.4.5 Meril Life Sciences Recent Developments
- 6.5 Genoss
- 6.5.1 Genoss Company Information
- 6.5.2 Genoss Business Overview
- 6.5.3 Genoss Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Genoss Hydrophilic Coronary Stents Product Portfolio
- 6.5.5 Genoss Recent Developments
- 6.6 Degania Silicone
- 6.6.1 Degania Silicone Company Information
- 6.6.2 Degania Silicone Business Overview
- 6.6.3 Degania Silicone Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Degania Silicone Hydrophilic Coronary Stents Product Portfolio
- 6.6.5 Degania Silicone Recent Developments
- 6.7 Cardionovum
- 6.7.1 Cardionovum Company Information
- 6.7.2 Cardionovum Business Overview
- 6.7.3 Cardionovum Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Cardionovum Hydrophilic Coronary Stents Product Portfolio
- 6.7.5 Cardionovum Recent Developments
7 North America by Country
- 7.1 North America Hydrophilic Coronary Stents Sales by Country
- 7.1.1 North America Hydrophilic Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hydrophilic Coronary Stents Sales by Country (2021-2026)
- 7.1.3 North America Hydrophilic Coronary Stents Sales Forecast by Country (2027-2032)
- 7.2 North America Hydrophilic Coronary Stents Market Size by Country
- 7.2.1 North America Hydrophilic Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hydrophilic Coronary Stents Market Size by Country (2021-2026)
- 7.2.3 North America Hydrophilic Coronary Stents Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hydrophilic Coronary Stents Sales by Country
- 8.1.1 Europe Hydrophilic Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hydrophilic Coronary Stents Sales by Country (2021-2026)
- 8.1.3 Europe Hydrophilic Coronary Stents Sales Forecast by Country (2027-2032)
- 8.2 Europe Hydrophilic Coronary Stents Market Size by Country
- 8.2.1 Europe Hydrophilic Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hydrophilic Coronary Stents Market Size by Country (2021-2026)
- 8.2.3 Europe Hydrophilic Coronary Stents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hydrophilic Coronary Stents Sales by Country
- 9.1.1 Asia-Pacific Hydrophilic Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hydrophilic Coronary Stents Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hydrophilic Coronary Stents Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hydrophilic Coronary Stents Market Size by Country
- 9.2.1 Asia-Pacific Hydrophilic Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hydrophilic Coronary Stents Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hydrophilic Coronary Stents Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hydrophilic Coronary Stents Sales by Country
- 10.1.1 South America Hydrophilic Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hydrophilic Coronary Stents Sales by Country (2021-2026)
- 10.1.3 South America Hydrophilic Coronary Stents Sales Forecast by Country (2027-2032)
- 10.2 South America Hydrophilic Coronary Stents Market Size by Country
- 10.2.1 South America Hydrophilic Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hydrophilic Coronary Stents Market Size by Country (2021-2026)
- 10.2.3 South America Hydrophilic Coronary Stents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hydrophilic Coronary Stents Sales by Country
- 11.1.1 Middle East and Africa Hydrophilic Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hydrophilic Coronary Stents Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hydrophilic Coronary Stents Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hydrophilic Coronary Stents Market Size by Country
- 11.2.1 Middle East and Africa Hydrophilic Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hydrophilic Coronary Stents Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hydrophilic Coronary Stents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hydrophilic Coronary Stents Value Chain Analysis
- 12.1.1 Hydrophilic Coronary Stents Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hydrophilic Coronary Stents Production Mode & Process
- 12.2 Hydrophilic Coronary Stents Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hydrophilic Coronary Stents Distributors
- 12.2.3 Hydrophilic Coronary Stents Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst